Stock listing
Stuttgart:RER1 Recordati S.p.A. Aktie
German listing (Stuttgart) of Recordati S.p.A. · home listing Milan:REC
Follow Recordati S.p.A. into a list and get an email when it puts out news.
Home listing price · MIL:REC
€52.75 EUR -0.05 (-0.1%)
Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, MIL:REC · Price from Euronext
- Day range
- €52.75 – €52.95 EURNov 19, 2026
- Volume
- 594,168 sharesNov 19, 2026
- Market cap
- €11.03B EURAt the close on Nov 19, 2026 · price × 209.1M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:RICFY | $14.65 USD | 0.00 (0.0%) | 230 | $14.65 | $14.65 | $14.65 | $14.65 | Close on Nov 20, 2026 |
| Frankfurt:RER1 | €52.70 EUR | -0.05 (-0.1%) | — | €52.55 | €52.75 | €52.55 | €52.75 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Oct 28, 2026 – Nov 19, 2026 · MIL:REC · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €52.75 | -0.05 | -0.1% | €52.85 | €52.95 | €52.75 | 594,168 | |
| €52.80 | -0.05 | -0.1% | €52.85 | €52.90 | €52.80 | 400,656 | |
| €52.85 | 0.00 | 0.0% | €52.85 | €52.95 | €52.85 | 438,105 | |
| €52.85 | +0.35 | +0.7% | €52.90 | €52.95 | €52.85 | 102,527 | |
| €52.50 | +0.05 | +0.1% | €52.45 | €52.70 | €52.45 | 5,262,517 | |
| €52.45 | -0.55 | -1.0% | €52.90 | €53.00 | €52.45 | 213,989 | |
| €53.00 | -0.10 | -0.2% | €53.05 | €53.15 | €52.75 | 275,929 | |
| €53.10 | -0.15 | -0.3% | €53.00 | €53.10 | €52.95 | 185,374 | |
| €53.25 | +0.15 | +0.3% | €53.00 | €53.25 | €52.95 | 283,335 | |
| €53.10 | +0.10 | +0.2% | €53.00 | €53.10 | €53.00 | 378,457 | |
| €53.00 | +0.05 | +0.1% | €52.95 | €53.05 | €52.95 | 378,842 | |
| €52.95 | -0.05 | -0.1% | €52.95 | €53.10 | €52.95 | 170,870 | |
| €53.00 | 0.00 | 0.0% | €53.00 | €53.05 | €52.95 | 240,541 | |
| €53.00 | +0.05 | +0.1% | €52.95 | €53.05 | €52.95 | 1,648,519 | |
| €52.95 | — | — | €52.85 | €53.05 | €52.75 | 141,771 |
- Ticker
- Stuttgart:RER1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
Recordati first nine months 2026: net revenue +7.5%, EBITDA +7.7%, Adjusted net income +6.4%
Latest earnings call · Jul 29, 2026
Recordati (Milan:REC) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
9M 2026 Earnings Presentation
Earnings · 17 slides
Latest news
Recordati first nine months 2026: net revenue +7.5%, EBITDA +7.7%, Adjusted net income +6.4%
Nov 10, 2026
Closed €52.45 (-1.0%) on Nov 11, 2026
Recordati S.p.A. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 12 in the last 12 months · 15 in all · newest Nov 10, 2026 · oldest 2025
- Calls
- 22 calls with a replay · 22 with a transcript · latest Jul 29, 2026
- Decks
- 162 decks · latest Nov 10, 2026
Where Recordati S.p.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Milan:REC · Home listing | Milan | Italy | EUR |
| OTC:RICFY | OTC | United States | USD |
| gettex:RER1 | gettex | Germany | EUR |
| VIE:REC | Vienna | Austria | EUR |
| OTC:RCDTF | OTC | United States | USD |
| Tradegate:RER1 | Tradegate | Germany | EUR |
| LS Exchange:A0EABR | LS Exchange | Germany | EUR |
| Turquoise:RECM | Turquoise | United Kingdom | EUR |
| Lang & Schwarz:A0EABR | Lang & Schwarz | Germany | EUR |
| LSIN:0KBS | LSIN | United Kingdom | EUR |
| Aquis:RECM | Aquis | United Kingdom | EUR |
| BMV:RECN | BMV | Mexico | MXN |
| Aquis:RECM | Aquis | United Kingdom | EUR |
| Stuttgart:RER1 · This page | Stuttgart | Germany | EUR |
| Frankfurt:RER1 | Frankfurt | Germany | EUR |
| Hanover:RER1 | Hanover | Germany | EUR |
| BIVA:RECN | BIVA | Mexico | MXN |
| Dusseldorf:RER1 | Dusseldorf | Germany | EUR |
| Hamburg:RER1 | Hamburg | Germany | EUR |
| Munich:RER1 | Munich | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Robert Koremans | Chief Executive Officer |
| Mike McClellan | Chief Financial Officer |
| Bibianne Bon | Group Chief Legal Officer |
| Silvia Signoretti | Group Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A |
| Eugenia Litz | Investor Relations |
| Alberto Martinez | Executive VP Specialty & Primary Care Business Unit |
| Alessandro Gilio | Executive VP Group Industrial Operations |
| Gabriele Finzi | Executive VP Corporate Development, Licensing & Innovation |
| Milan Zdravkovic | Executive VP Research & Development and Chief Medical Officer |
| Scott Pescatore | Executive VP Rare Diseases Business Unit |
| Alessandra Abate | Group Chief People and Culture Officer |
Board
| Director | Role |
|---|---|
| Andrea Recordati | Presidente |
| Cathrin Petty | |
| Diva Moriani | Indipendente e Lid |
| Giampiero Mazza | |
| Joanna Le Couilliard | Indipendente |
| Kim Stratton | |
| Luigi La Corte | |
| Piergiorgio Peluso | Indipendente |
| Robert Koremans | Chief Executive Officer |
| Stephen Sands | Indipendente |
Events
| Call | When | Status |
|---|---|---|
| Recordati (Milan:REC) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2026 Earnings Call | Wed, May 13, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2025 Earnings Call | Wed, Feb 18, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2025 Earnings Call | Wed, Nov 12, 2025 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2025 Earnings Call | Wed, Jul 30, 2025 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2024 Earnings Call | Fri, Nov 08, 2024 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2024 Earnings Call | Tue, Jul 30, 2024 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2023 Earnings Call | Fri, Jul 28, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2023 Earnings Call | Thu, May 11, 2023 · 11:00 AM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Recordati (Milan:REC) Q4 2022 Earnings Call | Tue, Feb 21, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2022 Earnings Call | Thu, Jul 28, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2022 Earnings Call | Tue, May 10, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2021 Earnings Call | Thu, Oct 28, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2021 Earnings Call | Thu, May 06, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2020 Earnings Call | Mon, Feb 22, 2021 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2020 Earnings Call | Fri, Oct 30, 2020 · 11:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2020 Earnings Call | Thu, Jul 30, 2020 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2020 Earnings Call | Thu, May 07, 2020 · 10:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 9M 2026 Earnings Presentation | Earnings | 17 slides | Nov 10, 2026 |
| Recordati Industria Chimica e Farmaceutica — H1 2026 Earnings Presentation | Earnings | 22 slides | Jul 29, 2026 |
| Recordati Industria Chimica e Farmaceutica — Q1 2026 Earnings Presentation | Earnings | 25 slides | May 13, 2026 |
| Recordati Industria Chimica e Farmaceutica — FY2025 Earnings Presentation | Earnings | 25 slides | Feb 18, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 13 slides | Jan 14, 2026 |
| Recordati Industria Chimica e Farmaceutica — Q3 2025 Earnings Presentation | Earnings | 24 slides | Nov 12, 2025 |
| Recordati Industria Chimica e Farmaceutica — H1 2025 Earnings Presentation | Earnings | 21 slides | Jul 30, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 21 slides | May 8, 2025 |
| Investor Day (April 2025) | Investor day | 45 slides | Apr 29, 2025 |
| FY2024 Earnings Presentation | Earnings | 23 slides | Feb 13, 2025 |
Show 50 decks
This page holds 50 of 162 decks. Open Decks
Financials
Annual, in EUR
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash and equivalents | 322.4M | 221.8M | 284.7M | 244.6M |
| Receivables | 361.9M | 307.8M | ||
| Current assets | 1.49B | 1.20B | 1.17B | 850.1M |
| Goodwill | 797.1M | 778.4M | 780.1M | 553.2M |
| Total assets | 5.13B | 4.21B | 4.00B | 2.82B |
| Accounts payable | 296.7M | 264.0M | 224.7M | 177.9M |
| Current liabilities | 929.1M | 1.00B | 923.7M | 626.4M |
| Shareholders' equity | 1.88B | 1.69B | 1.55B | 1.38B |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Dividends paid | -130.1M | -123.2M | -117.2M | -113.0M |
Cap table
Built by 6ix from Recordati S.p.A.’s releases
- Common shares
- 209,125,156
- Fully diluted
- 209,125,156
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 209,125,156 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 209,125,156 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alberto Martinez | Executive VP Specialty & Primary Care Business Unit · Since at least Nov 4, 2026 |
| Alessandra Abate | Group Chief People and Culture Officer · Since at least Nov 5, 2026 |
| Alessandro Gilio | Executive VP Group Industrial Operations · Since at least Nov 5, 2026 |
| Andrea Recordati | Presidente · Since at least Sep 17, 2026 |
| Bibianne Bon | Group Chief Legal Officer · Since at least Nov 5, 2026 |
| Cathrin Petty | Director · Since at least Apr 1, 2026 |
| Diva Moriani | Indipendente e Lid · Since at least Apr 1, 2026 |
| Eugenia Litz | Investor Relations · Since at least Jul 28, 2026 |
| Gabriele Finzi | Executive VP Corporate Development, Licensing & Innovation · Since at least Nov 5, 2026 |
| Giampiero Mazza | Director · Since at least Apr 1, 2026 |
All 20 people
| Person | Seat |
|---|---|
| Joanna Le Couilliard | Indipendente · Since at least Apr 1, 2026 |
| Kim Stratton | Director · Since at least Apr 1, 2026 |
| Luigi La Corte | Director · Since at least Apr 1, 2026 |
| Mike McClellan | Chief Financial Officer · Since at least Oct 23, 2025 |
| Milan Zdravkovic | Executive VP Research & Development and Chief Medical Officer · Since at least Nov 5, 2026 |
| Piergiorgio Peluso | Indipendente · Since at least Apr 1, 2026 |
| Robert Koremans | Chief Executive Officer · Since at least May 14, 2026 |
| Scott Pescatore | Executive VP Rare Diseases Business Unit · Since at least Nov 4, 2026 |
| Silvia Signoretti | Group Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A · Since at least Nov 5, 2026 |
| Stephen Sands | Indipendente · Since at least Apr 1, 2026 |
Log in to ask 6ix AI your own questions about Recordati S.p.A.